MoonLake announces completed submission of HS BLA to U.S. FDA for its nanobody Sonelokimab Sep 30 2026 MoonLake announces completed submission of HS BLA to U.S. FDA for its nanobody Sonelokimab 92.8 KB Back to Press Releases +
